Europe Algae Protein - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The european algae protein market size in 2026 is estimated at USD 79.72 million, growing from 2025 value of USD 72.93 million with 2031 projections showing USD 124.43 million, growing at 9.31% CAGR over 2026-2031. This report is Segmented by Source (Freshwater Algae and Marine Algae), Type (Spirulina, Chlorella, and Others), Application (Food and Beverages, Sport/Performance Nutrition, Elderly Nutrition and Medical Nutrition, and Animal Feed), and Geography (United Kingdom, Germany, France, Italy, Netherlands, Spain, and Rest of Europe). The Market Forecasts are Provided in Terms of Value (USD).

Europe Algae Protein Market Trends and Insights

High demand for plant-based food and supplements

Europe's surging appetite for plant-based foods and supplements is propelling the algae protein market, with applications spanning various industries. As consumers pivot towards sustainable, allergen-free, and nutrient-dense substitutes for animal protein, algae, especially spirulina and chlorella, are emerging as favorites. These algae boast a rich profile, packed with protein, essential amino acids, vitamins, and antioxidants. This rising preference dovetails with Europe's overarching sustainability and climate objectives, given that algae demand significantly less land, water, and energy than conventional crops or livestock. Furthermore, a surge in investments in alternative protein sources across Europe bolsters this market's expansion. Highlighting this trend, the Good Food Institute reported investments in alternative proteins in Germany amounted to EUR 134 million in 2024. Reflecting this burgeoning demand, the food and beverage sector is weaving algae protein into an array of products, from meat alternatives and protein bars to dairy-free yogurts, snacks, and beverages, tapping into the expanding vegan and flexitarian demographic.

Technological advancements in algae cultivation

The algae protein market is expanding through innovations in cultivation methods that focus on increasing yields, reducing production costs, and scaling operations. The implementation of closed-loop photobioreactor systems represents a significant technological advancement. These systems provide controlled environments that optimize light exposure, CO₂ levels, and nutrient distribution, resulting in higher biomass productivity compared to traditional open pond methods. The compact design of these systems enables efficient production for food, animal feed, and nutraceutical applications. In Germany, CellDEG GmbH's ultra-high-density thin-layer PBRs, with membrane-mediated CO₂ delivery, achieve impressive biomass concentrations over 30 g/L and daily productivity of around 10 g/L. Moreover, techniques in genetic engineering and strain selection have led to the cultivation of high-protein microalgae, such as Chlorella and Spirulina, boasting enhanced nutritional profiles and quicker growth. The rise of artificial intelligence (AI) and sensor-based monitoring further refines this process, enabling real-time adjustments for peak efficiency. Such advancements bolster the appeal of algae protein, making it a preferred choice over traditional proteins and paving the way for its broader acceptance in European food, aquafeed, and nutraceutical markets.

Sensory acceptance gap such as odor, flavor and texture

The sensory characteristics of algae protein present significant barriers to consumer acceptance, particularly its earthy, marine-like odor, bitter or grassy taste, and chalky or gritty texture. These attributes are particularly problematic in beverages, snacks, and dairy alternatives. European consumers generally prefer milder, neutral protein sources such as soy or pea, making the adoption of algae protein challenging in the functional food and sports nutrition markets, where taste and texture directly impact consumer repurchase decisions. European food technology companies are investing in solutions including deodorization technologies, microencapsulation, and blending techniques to address these sensory issues. However, these methods show variable results and increase production costs. Despite the technological advances, the persistent sensory issues continue to limit algae protein's integration into mainstream food products, affecting its growth in the European protein market.

Other drivers and restraints analyzed in the detailed report include:

• Expansion in functional foods and nutraceuticals
• Rising adoption of sustainable proteins
• High production costs

Segment Analysis

Freshwater species dominated the European algae protein market with 76.63% share in 2025, primarily through spirulina and chlorella cultivation. Marine microalgae, including Nannochloropsis, are growing at a 9.96% CAGR, driven by European Union authorization of edible seaweeds and increased demand for bioactive polysaccharides. In controlled freshwater environments such as ponds and photobioreactors, species like Spirulina and Chlorella thrive under carefully managed conditions, including nutrient levels, temperature, and light exposure. This controlled cultivation has established freshwater algae as a primary source for commercial protein products, supported by established supply chains and regulatory frameworks in Europe.

Marine algae, including seaweed and microalgae, are emerging as significant protein sources. Their nutritional composition features bioactive compounds like omega-3 fatty acids, antioxidants, and polysaccharides, making them valuable for functional foods and nutraceutical applications. Marine species cultivation in coastal or offshore locations offers scalability benefits and reduces freshwater usage, aligning with European environmental priorities. Advancements in farming and processing techniques are improving yields and product quality. These developments position marine algae to expand their market presence, complementing freshwater algae production and contributing to the growth of Europe's algae protein market.

Complete Report Scope:

• By Source
  • Freshwater Algae
  • Marine Algae
• By Type
  • Spirulina
  • Chlorella
  • Others
• By Application
  • Food and Beverages
    • Bakery
    • Dairy and Dairy Alternative Products
    • Meat/Poultry/Seafood and Meat Alternative Products
  • Sport/Performance Nutrition
  • Elderly Nutrition and Medical Nutrition
  • Animal Feed
• By Geography
  • United Kingdom
  • Germany
  • France
  • Italy
  • Netherlands
  • Spain
  • Rest of Europe

List of Companies Covered in this Report:

• Corbion N.V.
• Duplaco BV
• Phycom BV
• Algama Foods
• Aliga Microalgae A/S
• Bretagne Spiruline SARL
• AlgaeCytes Ltd.
• Cyanotech Corporation
• Triton Algae Innovations
• Botanic Healthcare
• AlgoSource S.A.
• NutraPharm
• Die Algenbauer
• Algenuity Limited
• Creative Enzymes
• Roquette Klötze GmbH & Co. KG
• Ecospirulina S.L.
• Aliga Microalgae
• PROTOGA BIOTECH LTD.
• Mibelle Biochemistry

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support